[A 45-year-old patient with a progressive, currently therapy-resistant disease of the lung].
König
G
G
Remberger
K
K
Höfling
B
B
Erdmann
E
E
Fruhmann
G
G
D000403:Airway Resistance / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D005448:Fluocortolone / Q000627:therapeutic use*; D006801:Humans; D008168:Lung / Q000473:pathology; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D011239:Prednisolone / Q000627:therapeutic use; D011653:Pulmonary Diffusing Capacity / Q000187:drug effects; D011658:Pulmonary Fibrosis / Q000188:drug therapy* / Q000473:pathology; D014109:Total Lung Capacity; D014797:Vital Capacity / Q000187:drug effects
D002245:Carbon Dioxide; D005448:Fluocortolone; D003520:Cyclophosphamide; D011239:Prednisolone; D010100:Oxygen
45jährige Patientin mit progredienter, zunächst therapieresistenter Lungengerüsterkrankung.